| Year |
Citation |
Score |
| 2020 |
Lu Y, Liu Y, Oeck S, Zhang GJ, Schramm A, Glazer PM. Hypoxia induces resistance to EGFR inhibitors in lung cancer cells via upregulation of FGFR1 and the MAPK pathway. Cancer Research. PMID 32873635 DOI: 10.1158/0008-5472.Can-20-1192 |
0.459 |
|
| 2019 |
Lu Y, Zhang GJ, Glazer PM. Abstract 312: Hypoxia induces EGFR inhibitor resistance in lung cancer cells via fibroblast growth factor receptor 1 (FGFR1) by promoting epithelial-mesenchymal transition (EMT) Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-312 |
0.457 |
|
| 2018 |
Lu Y, Liu Y, Oeck S, Glazer PM. Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1. Molecular Cancer Research : McR. PMID 29934325 DOI: 10.1158/1541-7786.Mcr-17-0637 |
0.455 |
|
| 2016 |
Teumer A, Qi Q, Nethander M, Aschard H, Bandinelli S, Beekman M, Berndt SI, Bidlingmaier M, Broer L, Cappola A, Ceda GP, Chanock S, Chen MH, Chen TC, ... ... Lu Y, et al. Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits. Aging Cell. PMID 27329260 DOI: 10.1111/Acel.12490 |
0.395 |
|
| 2016 |
Lu Y, Glazer PM. Abstract 736: Hypoxia-induced EGFR tyrosine kinase inhibitor resistance is associated with epithelial-mesenchymal transition in NSCLC Cancer Research. 76: 736-736. DOI: 10.1158/1538-7445.Am2016-736 |
0.438 |
|
| 2014 |
Cao C, Liu B, Zeng C, Lu Y, Chen S, Yang L, Li B, Li Y, Li Y. A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway. Cancer Cell International. 14: 137. PMID 25530716 DOI: 10.1186/s12935-014-0137-1 |
0.328 |
|
| 2014 |
Lu Y, Wajapeyee N, Turker MS, Glazer PM. Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1. Cell Reports. 8: 501-13. PMID 25043185 DOI: 10.1016/J.Celrep.2014.06.035 |
0.395 |
|
| 2013 |
Shen Q, Liu S, Chen Y, Yang L, Chen S, Wu X, Li B, Lu Y, Zhu K, Li Y. Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation. Journal of Hematology & Oncology. 6: 64. PMID 24004697 DOI: 10.1186/1756-8722-6-64 |
0.308 |
|
| 2013 |
Lu Y, Wajapeyee N, Turker MS, Glazer PM. Abstract 1513:MLH1silencing is caused by hypoxia through epigenetic regulation.. Cancer Research. 73: 1513-1513. DOI: 10.1158/1538-7445.Am2013-1513 |
0.376 |
|
| 2012 |
Lu Y, Glazer PM. Abstract 3939: Hypoxia-induced BRCA1 phosphorylation and degradation Cancer Research. 72: 3939-3939. DOI: 10.1158/1538-7445.Am2012-3939 |
0.39 |
|
| 2011 |
Lu Y, Chu A, Turker MS, Glazer PM. Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Molecular and Cellular Biology. 31: 3339-50. PMID 21670155 DOI: 10.1128/Mcb.01121-10 |
0.371 |
|
| 2010 |
Hegan DC, Lu Y, Stachelek GC, Crosby ME, Bindra RS, Glazer PM. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proceedings of the National Academy of Sciences of the United States of America. 107: 2201-6. PMID 20133863 DOI: 10.1073/Pnas.0904783107 |
0.425 |
|
| 2010 |
Hegan DC, Lu Y, Stachelek GC, Crosby ME, Bindra RS, Glazer PM. Abstract 1969: Inhibition of poly(ADP-ribose) polymerase downregulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130 Cancer Research. 70: 1969-1969. DOI: 10.1158/1538-7445.Am10-1969 |
0.438 |
|
| 2004 |
Lu Y, Zi X, Zhao Y, Pollak M. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells. Biochemical and Biophysical Research Communications. 313: 709-15. PMID 14697248 DOI: 10.1016/J.Bbrc.2003.12.007 |
0.551 |
|
| 2004 |
Lu Y, Zi X, Pollak M. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. International Journal of Cancer. 108: 334-41. PMID 14648698 DOI: 10.1002/Ijc.11445 |
0.56 |
|
| 2002 |
Camirand A, Lu Y, Pollak M. Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 8: BR521-6. PMID 12503030 |
0.529 |
|
| 2001 |
Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). Journal of the National Cancer Institute. 93: 1852-7. PMID 11752009 DOI: 10.1093/Jnci/93.24.1852 |
0.535 |
|
| Show low-probability matches. |